Dr. Siegel on Induction Therapy for Head and Neck Cancer | OncLive

Dr. Siegel on Induction Therapy for Head and Neck Cancer

August 28, 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

In head and neck cancer, when physicians are using induction therapy there have been 3 drugs that have been used, states Siegel. These are docetaxel, cisplatin, and 5-flourouracil (5-FU). According to Siegel, 5-FU adds more toxicity than efficacy.


x